Skip to main content

Table 1 Descriptive statistics (n /%) on covariates in SARS CoV-2 positive cases (n = 1069) and non-positive SARS CoV-2 participants (n = 120,305)a

From: The use of public transport and contraction of SARS-CoV-2 in a large prospective cohort in Norway

Variable

SARS-CoV-2 positive cases

Non-positive SARS-CoV-2 participants

Mean

SD

Mean

SD

Calendar time (date)

31.03.2020

9.5

01.04.2020

12.5

Age (years)

43

13.7

46

13.7

 

n

%

n

%

 P-valueb

< 0.0001

 18–25

129

12

6151

5

 26–30

117

11

10,237

8

 31–35

116

11

13,313

11

 36–40

114

11

13,989

12

 41–45

123

12

14,728

12

 46–50

130

12

15,595

13

 51–55

126

12

14,168

12

 56–60

101

9

10,712

9

 61–65

54

5

9076

8

 66–70

26

2

6722

6

 > 70

30

3

5300

4

 Missing

3

0

314

0

 

n

%

n

%

Sex

 Men

318

30

36,460

30

 Women

749

70

83,552

70

 Missing

2

0.2

293

0.2

 P-valuec

0.86

Income (NOK per household and year)

 Below 299,999

47

4

4058

3

 300,000–599,999

165

15

19,969

17

 600,000–1,000,000

272

26

31,305

26

 More than 1,000,000

401

38

44,251

37

 Missing

184

17

20,722

17

 P-valuec

0.35

Fitness

 Very fit

390

36

39,709

33

 Fairly fit

599

56

69,641

58

 In bad shape

80

8

10,864

9

 Missing

0

0

91

0

 P-valuec

0.04

Smoking habits

 Never

577

54

63,044

52

 Former

406

38

45,549

38

 Current

61

6

9111

8

 Missing

25

2

2602

2

 P-value c

0.14

Underlying medical conditionsd

 No

626

59

63,425

53

 Yes

283

26

36,792

30

 Missing

160

15

20,088

17

 P-valuec

0.001

  1. aThe statistical analyses were also adjusted for municipality (358 different municipalities)
  2. bMann-Whitney test comparing equality of medians
  3. cChi-squared test
  4. dChronic heart disease, high blood pressure, chronic lung disease (not asthma), asthma, diabetes, receiving immunodeficiency treatment, cancer (under treatment)